Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.
Pei-Hung ChangKun-Yun YehCheng-Hsu WangEric Yen-Chao ChenShih-Wei YangJen-Seng HuangWen-Chi ChouJason Chia-Hsun HsiehPublished in: Head & neck (2017)
Pretreatment Glasgow prognostic score predicts treatment tolerance, toxicity, and survival in patients with advanced head and neck cancer undergoing concurrent CRT.